Skip to main content
Addgene

In vivo interaction screening reveals liver-derived constraints to metastasis.

Borrelli C, Roberts M, Eletto D, Hussherr MD, Fazilaty H, Valenta T, Lafzi A, Kretz JA, Guido Vinzoni E, Karakatsani A, Adivarahan S, Mannhart A, Kimura S, Meijs A, Baccouche Mhamedi F, Acar IE, Handler K, Ficht X, Platt RJ, Piscuoglio S, Moor AE
Nature. 2024 Aug;632(8024):411-418. doi: 10.1038/s41586-024-07715-3. Epub 2024 Jul 24. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
239587pT4-U6-sgRNA-CMV-EGFPSleeping-beauty based EV for cloning and expression of sgRNAs - concomitant expression of GFP serves as transfection marker
239588sgPlxnb2-1 in pT4-U6-sgRNA-CMV-EGFPexpresses guide#1 to boost the expression of mouse Plxnb2, via CRISPRa
239589sgPlxnb2-2 in pT4-U6-sgRNA-CMV-EGFPexpresses guide#2 to boost the expression of mouse Plxnb2, via CRISPRa
239590sgPlxnb2-3 in pT4-U6-sgRNA-CMV-EGFPexpresses guide#3 to boost the expression of mouse Plxnb2, via CRISPRa
239591AAV-U6-sgRNA-EF1a-LibVecAAV vector for cloning and expression of sgRNAs - concomitant expression of GFP serves as transfection marker
239592AAV-U6-sgNT-1-EF1a-LibVecexpresses non-targeting (NT) guide#1
239593AAV-U6-sgNT-2-EF1a-LibVecexpresses non-targeting (NT) guide#2
239594AAV-U6-sgPlxnb2-CRISPRa-1-EF1a-LibVecexpresses guide#1 to boost the expression of mouse Plxnb2, via CRISPRa
239595AAV-U6-sgPlxnb2-CRISPRa-2-EF1a-LibVecexpresses guide#2 to boost the expression of mouse Plxnb2, via CRISPRa
239596AAV-U6-sgPlxnb2-CRISPRa-3-EF1a-LibVecexpresses guide#3 to boost the expression of mouse Plxnb2, via CRISPRa
239597AAV-U6-sgPlxnb2-KO-1-EF1a-LibVecexpresses guide#1 to knock-out mouse Plxnb2, via CRISPR-Cas9
239598AAV-U6-sgPlxnb2-KO-2-EF1a-LibVecexpresses guide#2 to knock-out mouse Plxnb2, via CRISPR-Cas9
239599AAV-U6-sgPlxnb2-KO-3-EF1a-LibVecexpresses guide#3 to knock-out mouse Plxnb2, via CRISPR-Cas9
239600AAV-U6-sgPlxnb2-KO-4-EF1a-LibVecexpresses guide#4 to knock-out mouse Plxnb2, via CRISPR-Cas9

Antibodies from Article